Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 2
2011 1
2013 1
2014 3
2015 3
2016 1
2017 6
2018 9
2019 8
2020 7
2021 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
CD123: A Novel Biomarker for Diagnosis and Treatment of Leukemia.
Shi M, Su RJ, Parmar KP, Chaudhry R, Sun K, Rao J, Chen M. Shi M, et al. Cardiovasc Hematol Disord Drug Targets. 2019;19(3):195-204. doi: 10.2174/1871529X19666190627100613. Cardiovasc Hematol Disord Drug Targets. 2019. PMID: 31244444 Review.
Blastic Plasmacytoid Dendritic Cell Neoplasm.
Kerr D 2nd, Zhang L, Sokol L. Kerr D 2nd, et al. Curr Treat Options Oncol. 2019 Feb 4;20(1):9. doi: 10.1007/s11864-019-0605-x. Curr Treat Options Oncol. 2019. PMID: 30715612 Review.
The interleukin-3 receptor CD123 targeted SL-401 mediates potent cytotoxic activity against CD34+CD123+ cells from acute myeloid leukemia/myelodysplastic syndrome patients and healthy donors.
Mani R, Goswami S, Gopalakrishnan B, Ramaswamy R, Wasmuth R, Tran M, Mo X, Gordon A, Bucci D, Lucas DM, Mims A, Brooks C, Dorrance A, Walker A, Blum W, Byrd JC, Lozanski G, Vasu S, Muthusamy N. Mani R, et al. Haematologica. 2018 Aug;103(8):1288-1297. doi: 10.3324/haematol.2018.188193. Epub 2018 May 17. Haematologica. 2018. PMID: 29773600 Free PMC article.
In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent.
Angelot-Delettre F, Roggy A, Frankel AE, Lamarthee B, Seilles E, Biichle S, Royer B, Deconinck E, Rowinsky EK, Brooks C, Bardet V, Benet B, Bennani H, Benseddik Z, Debliquis A, Lusina D, Roussel M, Solly F, Ticchioni M, Saas P, Garnache-Ottou F. Angelot-Delettre F, et al. Haematologica. 2015 Feb;100(2):223-30. doi: 10.3324/haematol.2014.111740. Epub 2014 Nov 7. Haematologica. 2015. PMID: 25381130 Free PMC article.
Development of a novel engineered antibody targeting human CD123.
Moradi-Kalbolandi S, Habibi-Anbouhi M, Golkar M, Behdani M, Rezaei G, Ghazizadeh L, Abolhassani M, Shokrgozar MA. Moradi-Kalbolandi S, et al. Anal Biochem. 2016 Oct 15;511:27-30. doi: 10.1016/j.ab.2016.04.017. Epub 2016 May 5. Anal Biochem. 2016. PMID: 27156812
37 results